Alexion Pharm Inc (ALXN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2013 | 06-2013 | 03-2013 | 12-2012 | 09-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 271,887 | 178,102 | 82,217 | 254,822 | 173,851 |
| Depreciation Amortization | 20,818 | 13,039 | 6,266 | 50,187 | 43,913 |
| Income taxes - deferred | 17,036 | 25,985 | 25,820 | 71,155 | 57,674 |
| Accounts receivable | -98,432 | -55,178 | -26,232 | -72,870 | -65,299 |
| Other Working Capital | 17,019 | -52,811 | -60,568 | -14,053 | -8,848 |
| Other Operating Activity | 60,140 | 35,056 | 18,994 | 121,372 | 104,365 |
| Operating Cash Flow | $288,468 | $144,193 | $46,497 | $410,613 | $305,656 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -393,037 | -183,320 | N/A | N/A | N/A |
| PPE Investments | -20,628 | -14,012 | -5,493 | -21,846 | -14,257 |
| Net Acquisitions | N/A | N/A | N/A | -605,735 | -605,735 |
| Other Investing Activity | -205 | -207 | -76 | -4 | -3 |
| Investing Cash Flow | $-413,870 | $-197,539 | $-5,569 | $-627,585 | $-619,995 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | 115,000 | 115,000 |
| Debt Issued | N/A | N/A | N/A | 240,000 | 240,000 |
| Debt Repayment | -24,000 | -12,000 | N/A | -91,000 | -79,000 |
| Common Stock Issued | 44,560 | 23,577 | 9,527 | 528,650 | 517,122 |
| Common Stock Repurchased | -66,136 | -66,136 | -35,107 | -11,553 | N/A |
| Other Financing Activity | 92,699 | 57,218 | 21,272 | -114,721 | -114,240 |
| Financing Cash Flow | $47,123 | $2,659 | $-4,308 | $666,376 | $678,882 |
| Exchange Rate Effect | -811 | -2,350 | -3,161 | -768 | 118 |
| Beginning Cash Position | 989,501 | 989,501 | 989,501 | 540,865 | 540,865 |
| End Cash Position | 910,411 | 936,464 | 1,022,960 | 989,501 | 905,526 |
| Net Cash Flow | $-79,090 | $-53,037 | $33,459 | $448,636 | $364,661 |
| Free Cash Flow | |||||
| Operating Cash Flow | 288,468 | 144,193 | 46,497 | 410,613 | 305,656 |
| Capital Expenditure | -20,628 | -14,012 | -5,493 | -21,846 | -14,257 |
| Free Cash Flow | 267,840 | 130,181 | 41,004 | 388,767 | 291,399 |